Matches in Nanopublications for { ?s ?p "[Pharmacologic inhibitors of IP3R, MPTP opening, and cyclophilin D could have clinical implications for primary open-angle glaucoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP638431.RAWSxlzPERvxxodTM6xbbzkOoEpiRTPL2HYuC_RyxtZAY130_assertion description "[Pharmacologic inhibitors of IP3R, MPTP opening, and cyclophilin D could have clinical implications for primary open-angle glaucoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP638431.RAWSxlzPERvxxodTM6xbbzkOoEpiRTPL2HYuC_RyxtZAY130_provenance.
- assertion description "[Pharmacologic inhibitors of IP3R, MPTP opening, and cyclophilin D could have clinical implications for primary open-angle glaucoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Pharmacologic inhibitors of IP3R, MPTP opening, and cyclophilin D could have clinical implications for primary open-angle glaucoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Pharmacologic inhibitors of IP3R, MPTP opening, and cyclophilin D could have clinical implications for primary open-angle glaucoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP681085.RADj2gVuPChIeJruzMuy40U1lXOq-UWlJQoa5zozTQCgI130_assertion description "[Pharmacologic inhibitors of IP3R, MPTP opening, and cyclophilin D could have clinical implications for primary open-angle glaucoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP681085.RADj2gVuPChIeJruzMuy40U1lXOq-UWlJQoa5zozTQCgI130_provenance.
- NP681086.RACTRZ1hnjvAmtAiY1zF7a2M4_e2nw4gy79ZHvQsnyeh4130_assertion description "[Pharmacologic inhibitors of IP3R, MPTP opening, and cyclophilin D could have clinical implications for primary open-angle glaucoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP681086.RACTRZ1hnjvAmtAiY1zF7a2M4_e2nw4gy79ZHvQsnyeh4130_provenance.
- NP518845.RA1LPQCvJLu8-TpDC-KuuctW-8KW1uyZdqwLl9EVvFFj0130_assertion description "[Pharmacologic inhibitors of IP3R, MPTP opening, and cyclophilin D could have clinical implications for primary open-angle glaucoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP518845.RA1LPQCvJLu8-TpDC-KuuctW-8KW1uyZdqwLl9EVvFFj0130_provenance.
- NP836537.RA_LSH8L3CDMZw2lhSCbGjgj71aBtae0QRQklu_wJgDGw130_assertion description "[Pharmacologic inhibitors of IP3R, MPTP opening, and cyclophilin D could have clinical implications for primary open-angle glaucoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP836537.RA_LSH8L3CDMZw2lhSCbGjgj71aBtae0QRQklu_wJgDGw130_provenance.
- NP681087.RA7HwUHkLqYHyuRaEH6AYTld6ClDqZz8tC1UUXKoTpyG0130_assertion description "[Pharmacologic inhibitors of IP3R, MPTP opening, and cyclophilin D could have clinical implications for primary open-angle glaucoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP681087.RA7HwUHkLqYHyuRaEH6AYTld6ClDqZz8tC1UUXKoTpyG0130_provenance.